BIOMAT Database Logo BIOMAT Database Logo

RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa). 1997

J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Université Catholique de Louvain, Cliniques Universitaires St-Luc, RBNT 5469, Brussels, Belgium.

OBJECTIVE Thorough knowledge of the RBE of clinical proton beams is indispensable for exploiting their full ballistic advantage. Therefore, the RBE of the 200-MeV clinical proton beam produced at the National Accelerator Centre of Faure (South Africa) was measured at different critical points of the depth-dose distribution. METHODS RBEs were determined at the initial plateau of the unmodulated and modulated beam (depth in Perspex = 43.5 mm), and at the beginning, middle and end of a 7-cm spread-out Bragg peak (SOBP) (depths in Perspex = 144.5, 165.5 and 191.5 mm, respectively). The biological system was the regeneration of intestinal crypts in mice after irradiation with a single fraction. RESULTS Using 60Co gamma-rays as the reference, the RBE values (for a gamma-dose of 14.38 Gy corresponding to 10 regenerated crypts) were found equal to 1.16 +/- 0.04, 1.10 +/- 0.03, 1.18 +/- 0.04, 1.12 +/- 0.03 and 1.23 +/- 0.03, respectively. At all depths, RBEs were found to increase slightly (about 4%) with decreasing dose, in the investigated dose range (12-17 Gy). No significant RBE variation with depth was observed, although RBEs in the SOBP were found to average a higher value (1.18 +/- 0.06) than in the entrance plateau (1.13 +/- 0.04). CONCLUSIONS An RBE value slightly larger than the current value of 1.10 should be adopted for clinical application with a 200-MeV proton beam.

UI MeSH Term Description Entries
D007414 Intestinal Neoplasms Tumors or cancer of the INTESTINES. Cancer of Intestines,Intestinal Cancer,Cancer of the Intestines,Intestines Cancer,Intestines Neoplasms,Neoplasms, Intestinal,Cancer, Intestinal,Cancer, Intestines,Cancers, Intestinal,Cancers, Intestines,Intestinal Cancers,Intestinal Neoplasm,Intestines Cancers,Intestines Neoplasm,Neoplasm, Intestinal,Neoplasm, Intestines,Neoplasms, Intestines
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009502 Neutrons Electrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay. Neutron
D010315 Particle Accelerators Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. Betatrons,Linear Accelerators,Accelerator, Linear,Accelerator, Particle,Accelerators, Linear,Accelerators, Particle,Betatron,Linear Accelerator,Particle Accelerator
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D012062 Relative Biological Effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. Biological Effectiveness, Relative,Effectiveness, Biologic Relative,Effectiveness, Biological Relative,Relative Biologic Effectiveness,Biologic Effectiveness, Relative,Biologic Relative Effectiveness,Biological Relative Effectiveness,Effectiveness, Relative Biologic,Effectiveness, Relative Biological,Relative Effectiveness, Biologic
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt

Related Publications

J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Faure Hospital at the National Accelerator Centre.
January 1989, Nursing RSA = Verpleging RSA,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
RBE and OER measurements on the p(66) + Be neutron beam at Faure, South Africa.
January 1992, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Changes in the relative biological effectiveness (RBE) of a 35 Mev. electron beam as a function of tissue depth.
August 1966, The American journal of roentgenology, radium therapy, and nuclear medicine,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Establishment of a beam line at the Fermi National Accelerator Laboratory for proton radiography.
January 1978, Medical physics,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Chromosome aberration frequencies produced by a 70-MeV proton beam.
August 1990, Radiation research,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
THE TOP-IMPLART PROTON LINEAR ACCELERATOR: INTERIM CHARACTERISTICS OF THE 35 MEV BEAM.
December 2019, Radiation protection dosimetry,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Beam characterisation studies of the 62 MeV proton therapy beamline at the Clatterbridge Cancer Centre.
September 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB),
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
CHARACTERIZATION OF 27 MEV PROTON BEAM GENERATED BY TOP-IMPLART LINEAR ACCELERATOR.
August 2018, Radiation protection dosimetry,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Measurement of neutron leakage spectra at a 500-MeV proton accelerator.
March 1989, Health physics,
J Gueulette, and L Böhm, and B M De Coster, and S Vynckier, and M Octave-Prignot, and A N Schreuder, and J E Symons, and D T Jones, and A Wambersie, and P Scalliet
Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
January 2013, Radiation research,
Copied contents to your clipboard!